Human papillomavirus (HPV)

WHO adds single-use HPV vaccine

WHO announced that the use of Cecolin, the fourth WHO prequalified human papillomavirus (HPV) vaccine, has been confirmed for use…

1 month ago

WHO suggests passive immunization against RSV through maternal vaccination.

The WHO Strategic Advisory Group on Immunization (SAGE) announced on Tuesday its recommendation that countries introduce passive immunization against respiratory…

2 months ago

GeSIDA recommends broadening PrEP access criteria to improve access

On the occasion of the fifth anniversary of the inclusion of PrEP (pre-exposure prophylaxis for HIV) in the NHS core…

2 months ago

Immunotherapy is included in the therapeutic algorithm for head and neck cancer.

In recent years, the inclusion of immunotherapy in the therapeutic algorithm of patients with PD-L1-positive advanced head and neck cancer…

4 months ago

According to the WHO, vaccines have saved at least 154 million lives over the past 50 years.

Landmark WHO study to be published in The Lancet shows global immunization efforts have generated savings approximately 154 million lives…

7 months ago

HPV is a pathology that is common to everyone, regardless of gender, age or orientation.

“Nearly 80% of the sexually active population will be exposed to HPV at some point in their lives.” This was…

9 months ago

ESMO demands ‘special attention’ from European Cancer Plan on access to innovation

“With this Manifesto, we express our commitment to supporting European institutions, as well as national decision-makers, in the development, implementation…

10 months ago

The ‘post-Covid era’ offers a promising future for new vaccine development

Vaccination interventions are expanding to new diseases and target populations; In addition, vaccines are easier and faster to produce, more…

10 months ago